Table of Contents Chapter 1 Overview of Influenza Vaccine 1.1 Definition of Influenza Vaccine in This Report 1.2 Commercial Types of Influenza Vaccine 1.2.1 Trivalent Influenza Vaccine 1.2.2 Quadrivalent Influenza Vaccine 1.2.3 Other 1.3 Downstream Application of Influenza Vaccine 1.3.1 Children 1.3.2 Adults 1.3.3 Elderly 1.3.4 Pregnancy 1.4 Development History of Influenza Vaccine 1.5 Market Status and Trend of Influenza Vaccine 2013-2023 1.5.1 United States Influenza Vaccine Market Status and Trend 2013-2023 1.5.2 Regional Influenza Vaccine Market Status and Trend 2013-2023 Chapter 2 United States Market Status and Forecast by Regions 2.1 Market Status of Influenza Vaccine in United States 2013-2017 2.2 Consumption Market of Influenza Vaccine in United States by Regions 2.2.1 Consumption Volume of Influenza Vaccine in United States by Regions 2.2.2 Revenue of Influenza Vaccine in United States by Regions 2.3 Market Analysis of Influenza Vaccine in United States by Regions 2.3.1 Market Analysis of Influenza Vaccine in New England 2013-2017 2.3.2 Market Analysis of Influenza Vaccine in The Middle Atlantic 2013-2017 2.3.3 Market Analysis of Influenza Vaccine in The Midwest 2013-2017 2.3.4 Market Analysis of Influenza Vaccine in The West 2013-2017 2.3.5 Market Analysis of Influenza Vaccine in The South 2013-2017 2.3.6 Market Analysis of Influenza Vaccine in Southwest 2013-2017 2.4 Market Development Forecast of Influenza Vaccine in United States 2018-2023 2.4.1 Market Development Forecast of Influenza Vaccine in United States 2018-2023 2.4.2 Market Development Forecast of Influenza Vaccine by Regions 2018-2023 Chapter 3 United States Market Status and Forecast by Types 3.1 Whole United States Market Status by Types 3.1.1 Consumption Volume of Influenza Vaccine in United States by Types 3.1.2 Revenue of Influenza Vaccine in United States by Types 3.2 United States Market Status by Types in Major Countries 3.2.1 Market Status by Types in New England 3.2.2 Market Status by Types in The Middle Atlantic 3.2.3 Market Status by Types in The Midwest 3.2.4 Market Status by Types in The West 3.2.5 Market Status by Types in The South 3.2.6 Market Status by Types in Southwest 3.3 Market Forecast of Influenza Vaccine in United States by Types Chapter 4 United States Market Status and Forecast by Downstream Industry 4.1 Demand Volume of Influenza Vaccine in United States by Downstream Industry 4.2 Demand Volume of Influenza Vaccine by Downstream Industry in Major Countries 4.2.1 Demand Volume of Influenza Vaccine by Downstream Industry in New England 4.2.2 Demand Volume of Influenza Vaccine by Downstream Industry in The Middle Atlantic 4.2.3 Demand Volume of Influenza Vaccine by Downstream Industry in The Midwest 4.2.4 Demand Volume of Influenza Vaccine by Downstream Industry in The West 4.2.5 Demand Volume of Influenza Vaccine by Downstream Industry in The South 4.2.6 Demand Volume of Influenza Vaccine by Downstream Industry in Southwest 4.3 Market Forecast of Influenza Vaccine in United States by Downstream Industry Chapter 5 Market Driving Factor Analysis of Influenza Vaccine 5.1 United States Economy Situation and Trend Overview 5.2 Influenza Vaccine Downstream Industry Situation and Trend Overview Chapter 6 Influenza Vaccine Market Competition Status by Major Players in United States 6.1 Sales Volume of Influenza Vaccine in United States by Major Players 6.2 Revenue of Influenza Vaccine in United States by Major Players 6.3 Basic Information of Influenza Vaccine by Major Players 6.3.1 Headquarters Location and Established Time of Influenza Vaccine Major Players 6.3.2 Employees and Revenue Level of Influenza Vaccine Major Players 6.4 Market Competition News and Trend 6.4.1 Merger, Consolidation or Acquisition News 6.4.2 Investment or Disinvestment News 6.4.3 New Product Development and Launch Chapter 7 Influenza Vaccine Major Manufacturers Introduction and Market Data 7.1 GSK 7.1.1 Company profile 7.1.2 Representative Influenza Vaccine Product 7.1.3 Influenza Vaccine Sales, Revenue, Price and Gross Margin of GSK 7.2 Sinovac 7.2.1 Company profile 7.2.2 Representative Influenza Vaccine Product 7.2.3 Influenza Vaccine Sales, Revenue, Price and Gross Margin of Sinovac 7.3 Changsheng 7.3.1 Company profile 7.3.2 Representative Influenza Vaccine Product 7.3.3 Influenza Vaccine Sales, Revenue, Price and Gross Margin of Changsheng 7.4 CCBIO 7.4.1 Company profile 7.4.2 Representative Influenza Vaccine Product 7.4.3 Influenza Vaccine Sales, Revenue, Price and Gross Margin of CCBIO 7.5 Aleph Biomedical 7.5.1 Company profile 7.5.2 Representative Influenza Vaccine Product 7.5.3 Influenza Vaccine Sales, Revenue, Price and Gross Margin of Aleph Biomedical 7.6 Sanofi 7.6.1 Company profile 7.6.2 Representative Influenza Vaccine Product 7.6.3 Influenza Vaccine Sales, Revenue, Price and Gross Margin of Sanofi 7.7 Lanzhou Institute Of Biological Product 7.7.1 Company profile 7.7.2 Representative Influenza Vaccine Product 7.7.3 Influenza Vaccine Sales, Revenue, Price and Gross Margin of Lanzhou Institute Of Biological Product 7.8 Siobp 7.8.1 Company profile 7.8.2 Representative Influenza Vaccine Product 7.8.3 Influenza Vaccine Sales, Revenue, Price and Gross Margin of Siobp 7.9 Hualan Bio 7.9.1 Company profile 7.9.2 Representative Influenza Vaccine Product 7.9.3 Influenza Vaccine Sales, Revenue, Price and Gross Margin of Hualan Bio 7.10 Tianyuan Bio-Pharma 7.10.1 Company profile 7.10.2 Representative Influenza Vaccine Product 7.10.3 Influenza Vaccine Sales, Revenue, Price and Gross Margin of Tianyuan Bio-Pharma 7.11 Vaxtec 7.11.1 Company profile 7.11.2 Representative Influenza Vaccine Product 7.11.3 Influenza Vaccine Sales, Revenue, Price and Gross Margin of Vaxtec 7.12 Hissen 7.12.1 Company profile 7.12.2 Representative Influenza Vaccine Product 7.12.3 Influenza Vaccine Sales, Revenue, Price and Gross Margin of Hissen 7.13 Abbott 7.13.1 Company profile 7.13.2 Representative Influenza Vaccine Product 7.13.3 Influenza Vaccine Sales, Revenue, Price and Gross Margin of Abbott 7.14 Novartis 7.14.1 Company profile 7.14.2 Representative Influenza Vaccine Product 7.14.3 Influenza Vaccine Sales, Revenue, Price and Gross Margin of Novartis 7.15 Tasly&Jenner 7.15.1 Company profile 7.15.2 Representative Influenza Vaccine Product 7.15.3 Influenza Vaccine Sales, Revenue, Price and Gross Margin of Tasly&Jenner 7.16 Tiantan Chapter 8 Upstream and Downstream Market Analysis of Influenza Vaccine 8.1 Industry Chain of Influenza Vaccine 8.2 Upstream Market and Representative Companies Analysis 8.3 Downstream Market and Representative Companies Analysis Chapter 9 Cost and Gross Margin Analysis of Influenza Vaccine 9.1 Cost Structure Analysis of Influenza Vaccine 9.2 Raw Materials Cost Analysis of Influenza Vaccine 9.3 Labor Cost Analysis of Influenza Vaccine 9.4 Manufacturing Expenses Analysis of Influenza Vaccine Chapter 10 Marketing Status Analysis of Influenza Vaccine 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.1.3 Marketing Channel Development Trend 10.2 Market Positioning 10.2.1 Pricing Strategy 10.2.2 Brand Strategy 10.2.3 Target Client 10.3 Distributors/Traders List Chapter 11 Report Conclusion Chapter 12 Research Methodology and Reference 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Reference

List of Tables Table Advantage and Disadvantage of Trivalent Influenza Vaccine Table Advantage and Disadvantage of Quadrivalent Influenza Vaccine Table Advantage and Disadvantage of Other Table Consumption Volume of Influenza Vaccine in United States by Regions 2013-2017 Table Revenue of Influenza Vaccine in United States by Regions 2013-2017 Table Consumption Volume of Influenza Vaccine in United States by Regions 2018-2023 Table Revenue of Influenza Vaccine in United States by Regions 2018-2023 Table Consumption Volume of Influenza Vaccine in United States by Types 2013-2017 Table Revenue of Influenza Vaccine in United States by Types 2013-2017 Table Consumption Volume of Influenza Vaccine by Types in New England 2013-2017 Table Consumption Volume of Influenza Vaccine by Types in The Middle Atlantic 2013-2017 Table Consumption Volume of Influenza Vaccine by Types in The Midwest 2013-2017 Table Consumption Volume of Influenza Vaccine by Types in The West 2013-2017 Table Consumption Volume of Influenza Vaccine by Types in The South 2013-2017 Table Consumption Volume of Influenza Vaccine by Types in Southwest 2013-2017 Table Consumption Volume Forecast of Influenza Vaccine in United States by Types 2018-2023 Table Revenue Forecast of Influenza Vaccine in United States by Types 2018-2023 Table Demand Volume of Influenza Vaccine in United States by Downstream Industry 2013-2017 Table Demand Volume of Influenza Vaccine by Downstream Industry in New England 2013-2017 Table Demand Volume of Influenza Vaccine by Downstream Industry in The Middle Atlantic 2013-2017 Table Demand Volume of Influenza Vaccine by Downstream Industry in The Midwest 2013-2017 Table Demand Volume of Influenza Vaccine by Downstream Industry in The West 2013-2017 Table Demand Volume of Influenza Vaccine by Downstream Industry in The South 2013-2017 Table Demand Volume of Influenza Vaccine by Downstream Industry in Southwest 2013-2017 Table Demand Volume Forecast of Influenza Vaccine in United States by Downstream Industry 2018-2023 Table Sales Volume of Influenza Vaccine in United States by Major Players 2013-2017 Table Revenue of Influenza Vaccine in United States by Major Players 2013-2017 Table Headquarters Location and Established Time of Influenza Vaccine Major Players Table Employees and Revenue Level of Influenza Vaccine Major Players Table Representative Influenza Vaccine Product One of GSK Table Representative Influenza Vaccine Product Two of GSK Table Influenza Vaccine Sales, Revenue, Price and Gross Margin of GSK 2013-2017 Table Representative Influenza Vaccine Product One of Sinovac Table Representative Influenza Vaccine Product Two of Sinovac Table Influenza Vaccine Sales, Revenue, Price and Gross Margin of Sinovac 2013-2017 Table Representative Influenza Vaccine Product One of Changsheng Table Representative Influenza Vaccine Product Two of Changsheng Table Influenza Vaccine Sales, Revenue, Price and Gross Margin of Changsheng 2013-2017 Table Representative Influenza Vaccine Product One of CCBIO Table Representative Influenza Vaccine Product Two of CCBIO Table Influenza Vaccine Sales, Revenue, Price and Gross Margin of CCBIO 2013-2017 Table Representative Influenza Vaccine Product One of Aleph Biomedical Table Representative Influenza Vaccine Product Two of Aleph Biomedical Table Influenza Vaccine Sales, Revenue, Price and Gross Margin of Aleph Biomedical 2013-2017 Table Representative Influenza Vaccine Product One of Sanofi Table Representative Influenza Vaccine Product Two of Sanofi Table Influenza Vaccine Sales, Revenue, Price and Gross Margin of Sanofi 2013-2017 Table Representative Influenza Vaccine Product One of Lanzhou Institute Of Biological Product Table Representative Influenza Vaccine Product Two of Lanzhou Institute Of Biological Product Table Influenza Vaccine Sales, Revenue, Price and Gross Margin of Lanzhou Institute Of Biological Product 2013-2017 Table Representative Influenza Vaccine Product One of Siobp Table Representative Influenza Vaccine Product Two of Siobp Table Influenza Vaccine Sales, Revenue, Price and Gross Margin of Siobp 2013-2017 Table Representative Influenza Vaccine Product One of Hualan Bio Table Representative Influenza Vaccine Product Two of Hualan Bio Table Influenza Vaccine Sales, Revenue, Price and Gross Margin of Hualan Bio 2013-2017 Table Representative Influenza Vaccine Product One of Tianyuan Bio-Pharma Table Representative Influenza Vaccine Product Two of Tianyuan Bio-Pharma Table Influenza Vaccine Sales, Revenue, Price and Gross Margin of Tianyuan Bio-Pharma 2013-2017 Table Representative Influenza Vaccine Product One of Vaxtec Table Representative Influenza Vaccine Product Two of Vaxtec Table Influenza Vaccine Sales, Revenue, Price and Gross Margin of Vaxtec 2013-2017 Table Representative Influenza Vaccine Product One of Hissen Table Representative Influenza Vaccine Product Two of Hissen Table Influenza Vaccine Sales, Revenue, Price and Gross Margin of Hissen 2013-2017 Table Representative Influenza Vaccine Product One of Abbott Table Representative Influenza Vaccine Product Two of Abbott Table Influenza Vaccine Sales, Revenue, Price and Gross Margin of Abbott 2013-2017 Table Representative Influenza Vaccine Product One of Novartis Table Representative Influenza Vaccine Product Two of Novartis Table Influenza Vaccine Sales, Revenue, Price and Gross Margin of Novartis 2013-2017 Table Representative Influenza Vaccine Product One of Tasly&Jenner Table Representative Influenza Vaccine Product Two of Tasly&Jenner Table Influenza Vaccine Sales, Revenue, Price and Gross Margin of Tasly&Jenner 2013-2017